Molecular Templates Inc (MTEM)
NASDAQ:MTEM

Molecular Templates (MTEM) Stock Price & Analysis

490 Followers

MTEM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.31 - $3.64
Previous Close$0.53
Volume175.69K
Average Volume (3M)164.61K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$79.44M
Total Debt (Recent Filing)$50.32M
Price to Earnings (P/E)-0.4
Beta1.09
Next EarningsMar 29, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.44
Shares Outstanding56,351,647
R-Squared0.11
Standard Deviation0.20
10 Day Avg. Volume126,034
30 Day Avg. Volume164,610
Price to Book (P/B)6.24
Price to Sales (P/S)1.64
Price to Cash Flow (P/CF)23.40
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside89.29% Upside
Rating ConsensusModerate Buy
Alpha-0.04
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

MTEM FAQ

What was Molecular Templates’s price range in the past 12 months?
Molecular Templates lowest stock price was $0.31 and its highest was $3.64 in the past 12 months.
    What is Molecular Templates’s market cap?
    Currently, no data Available
    When is Molecular Templates’s upcoming earnings report date?
    Molecular Templates’s upcoming earnings report date is Mar 29, 2023 which is in 61 days.
      How were Molecular Templates’s earnings last quarter?
      Molecular Templates released its earnings results on Nov 10, 2022. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.486 by $0.046.
        Is Molecular Templates overvalued?
        According to Wall Street analysts Molecular Templates’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Molecular Templates pay dividends?
          Molecular Templates does not currently pay dividends.
          What is Molecular Templates’s EPS estimate?
          Molecular Templates’s EPS estimate is -$0.32.
            How many shares outstanding does Molecular Templates have?
            Molecular Templates has 56,351,646 shares outstanding.
              What happened to Molecular Templates’s price movement after its last earnings report?
              Molecular Templates reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.486. Following the earnings report the stock price went up 7.143%.
                Which hedge fund is a major shareholder of Molecular Templates?
                Among the largest hedge funds holding Molecular Templates’s share is Woodline Partners LP. It holds Molecular Templates’s shares valued at N/A.

                  ---

                  Molecular Templates Stock Smart Score

                  N/A
                  Not Ranked
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -82.22%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -212.21%
                  Trailing 12-Months
                  Asset Growth
                  -45.56%
                  Trailing 12-Months
                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Molecular Templates Inc

                  Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded on October 17, 2001 and is headquartered in Austin, TX.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Vicapsys Life Sciences
                  Arca Biopharma
                  Pasithea Therapeutics Corp
                  Comera Life Sciences Holdings
                  NightHawk Biosciences

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis